Galapagos reported -21146000 in EBIT for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
AstraZeneca AZN:LN 2.88B 1.57B
Biogen BIIB:US $ 531.5M 11.7M
Genmab GEN:DC 514M 295M
Gilead Sciences GILD:US $ 2897M 1957M
GlaxoSmithKline GSK:LN 2.42B 724M
GRIFOLS GRF:SM 244.2M 75.33M
H. Lundbeck A/S LUN:DC 875M 869M
Hikma Pharmaceutical HIK:LN 279M 1000K
Merck MRK:GR 1.2B 186M
Neurocrine Biosciences NBIX:US $ 3.1M 60.9M
Novartis NOVN:VX 3.15B 266M
Vertex Pharmaceuticals VRTX:US $ 1033.4M 157.68M
YTE INCY:US $ 127.66M 7.71M